These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 24001294)

  • 21. Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users.
    Bonn-Miller MO; Boden MT; Bucossi MM; Babson KA
    Am J Drug Alcohol Abuse; 2014 Jan; 40(1):23-30. PubMed ID: 24205805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is the party over? Cannabis and juvenile psychiatric disorder: the past 10 years.
    Rey JM; Martin A; Krabman P
    J Am Acad Child Adolesc Psychiatry; 2004 Oct; 43(10):1194-205. PubMed ID: 15381886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antecedents and consequences of cannabis use among racially diverse cannabis users: an analysis from Ecological Momentary Assessment.
    Buckner JD; Zvolensky MJ; Crosby RD; Wonderlich SA; Ecker AH; Richter A
    Drug Alcohol Depend; 2015 Feb; 147():20-5. PubMed ID: 25578250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medical cannabis and mental health: A guided systematic review.
    Walsh Z; Gonzalez R; Crosby K; S Thiessen M; Carroll C; Bonn-Miller MO
    Clin Psychol Rev; 2017 Feb; 51():15-29. PubMed ID: 27816801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comorbidity in 207 cannabis users in a specific outpatient setting].
    Guillem E; Arbabzadeh-Bouchez S; Vorspan F; Bellivier F
    Encephale; 2015 Jun; 41 Suppl 1():S7-12. PubMed ID: 25123065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabis Hyperemesis Syndrome in Palliative Care: A Case Study and Narrative Review.
    Howard I
    J Palliat Med; 2019 Oct; 22(10):1227-1231. PubMed ID: 31084461
    [No Abstract]   [Full Text] [Related]  

  • 28. Cannabis use in people with severe mental illness: The association with physical and mental health--a cohort study. A Pharmacotherapy Monitoring and Outcome Survey study.
    Bruins J; Pijnenborg MG; Bartels-Velthuis AA; Visser E; van den Heuvel ER; Bruggeman R; Jörg F
    J Psychopharmacol; 2016 Apr; 30(4):354-62. PubMed ID: 26883305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pros and Cons of Medical Cannabis use by People with Chronic Brain Disorders.
    Suryadevara U; Bruijnzeel DM; Nuthi M; Jagnarine DA; Tandon R; Bruijnzeel AW
    Curr Neuropharmacol; 2017; 15(6):800-814. PubMed ID: 27804883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perceived risk associated with tobacco, alcohol and cannabis use among people with and without psychotic disorders.
    Thornton LK; Baker AL; Johnson MP; Lewin T
    Addict Behav; 2013 Jun; 38(6):2246-51. PubMed ID: 23507458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Psychiatric complications of cannabis use].
    Coscas S; Benyamina A; Reynaud M; Karila L
    Rev Prat; 2013 Dec; 63(10):1426-8. PubMed ID: 24579344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and correlates of sleep-related problems in adults receiving medical cannabis for chronic pain.
    Cranford JA; Arnedt JT; Conroy DA; Bohnert KM; Bourque C; Blow FC; Ilgen M
    Drug Alcohol Depend; 2017 Nov; 180():227-233. PubMed ID: 28926791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse effects of cannabis on health: an update of the literature since 1996.
    Kalant H
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Aug; 28(5):849-63. PubMed ID: 15363608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The adverse health effects of chronic cannabis use.
    Hall W; Degenhardt L
    Drug Test Anal; 2014; 6(1-2):39-45. PubMed ID: 23836598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cannabis cessation interventions offered to young French users: predictors of follow-up].
    Abdoul H; Le Faou AL; Bouchez J; Touzeau D; Lagrue G
    Encephale; 2012 Apr; 38(2):141-8. PubMed ID: 22516272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recreational stimulants, herbal, and spice cannabis: The core psychobiological processes that underlie their damaging effects.
    Parrott AC; Hayley AC; Downey LA
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28557129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The adverse health effects of cannabis use: what are they, and what are their implications for policy?
    Hall W
    Int J Drug Policy; 2009 Nov; 20(6):458-66. PubMed ID: 19362460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cannabis for chronic neuropathic pain.].
    Cuestas E
    Rev Fac Cien Med Univ Nac Cordoba; 2019 Mar; 76(1):1-2. PubMed ID: 30882335
    [No Abstract]   [Full Text] [Related]  

  • 39. Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors.
    Lucas P; Walsh Z; Crosby K; Callaway R; Belle-Isle L; Kay R; Capler R; Holtzman S
    Drug Alcohol Rev; 2016 May; 35(3):326-33. PubMed ID: 26364922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabis and neuropsychiatry, 1: benefits and risks.
    Andrade C
    J Clin Psychiatry; 2016 May; 77(5):e551-4. PubMed ID: 27249079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.